Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Blood Adv
.
2024 Oct 9:bloodadvances.2024014255.
doi: 10.1182/bloodadvances.2024014255.
Online ahead of print.
Authors
Zachary M Avigan
1
,
Saoirse Bodnar
1
,
Darren Pan
2
,
Jerrel Lewis Catlett 2nd
1
,
Joshua Richter
3
,
Larysa J Sanchez
1
,
Cesar Rodriguez
1
,
Adriana C Rossi
1
,
Shambavi Richard
1
,
Sundar Jagannath
4
,
Hearn Jay Cho
5
,
Samir Parekh
6
,
Santiago Thibaud
1
Affiliations
1
Icahn School of Medicine at Mount Sinai, New York, New York, United States.
2
University of California, San Francisco, San Francisco, California, United States.
3
1. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
4
Mt. Sinai Medical Center, New York, New York, United States.
5
Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai, New York, New York, United States.
6
Icahn School of Medicine at Mount Sinai, NEW YORK, New York, United States.
PMID:
39383457
DOI:
10.1182/bloodadvances.2024014255
No abstract available